An official website of the United States government
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
This publication is provided for historical reference only and the information may be out of date.
CADTH Health Technology Assessments, now renamed to Health Technology Review, are comprehensive reviews of health technologies, including drugs, devices, systems, and services. They usually examine more mature technologies for which there is a larger and higher quality body of evidence available. Clinical and cost-effectiveness and the broader impact on both patient health and the health care system are examined. CADTH Health Technology Assessments may include information on the social, ethical, and economic implications of using a technology compared with using alternative treatments, and may also include information on patient indications, current treatment practices, regulatory issues, adverse effects, and health services impact. Selected topics are those that are of widespread interest to the Canadian publicly funded health care system.
The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent, not-for-profit producer and broker of health technology assessments. Health care decision-makers rely on our work to make evidence-informed policy and practice decisions about drugs and other health technologies.
CADTH Health Technology Assessments was renamed to Health Technology Review on on Oct. 29, 2021.
Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial- NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
Your browsing activity is empty.
Activity recording is turned off.
See more...
